Growth

Gonadorelin.

Available Variants

2 mg

View lab reports Quality process

Research area: Growth

🛡️

For research purposes only. Not intended for use in humans or animals.

GH-axis research

About Gonadorelin

Gonadorelin is among the peptides researched in the context of the growth hormone (GH) axis. Binds GnRH receptors on pituitary gonadotrope cells, stimulating pulsatile release of LH and FSH, which drive gonadal steroidogenesis — the basis of the hypothalamic-pituitary-gonadal (HPG) axis.

Research Application

Used as the reference substance for the GnRH stimulation test to assess pituitary gonadotropin reserve, and to study pulsatile versus continuous GnRH-receptor signaling.

Important to know

Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.

Content 2 mg

Form Lyophilized powder

Category Growth

Purity & Identity see lab reports →

Sequence / Structure Native decapeptide, identical to endogenous GnRH: pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2.

Regulatory Status Historically FDA-approved as Factrel and Lutrepulse; both were withdrawn from the US market. No FDA-approved gonadorelin product is currently marketed in the US; available via compounding pharmacies. Discoverers Schally and Guillemin received the 1977 Nobel Prize in Physiology or Medicine for elucidating GnRH.

Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.

Research Overview

Numerous preclinical and some clinical studies exist on the GH axis, with evidentiary strength varying by substance.

Specific study references will be added for this product. For current literature, independent research (e.g. via PubMed) is recommended.

Similar Peptides

Growth Triptorelin View → Growth HCG View → Growth HMG View → Focus Kisspeptin-10 View →

Question about Gonadorelin?

We reply personally – via email or Telegram.

✉️ Email ✈️ Telegram

← Back to overview